Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
US6291672A · kind A · utility
2Cited by
6References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 1999 |
| Grant date | Sep 18, 2001 |
| Priority date | — |
| Expiry date | Nov 9, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula ##STR1## are useful as human NK3 receptor antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.